Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remimazolam for Colonoscopy in IBD Patients

NCT07161297 is registered in ClinicalTrials.gov with Humanitas Clinical and Research Center as lead sponsor.

NCT NCT07161297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remimazolam for Colonoscopy in IBD Patients
Lead sponsor
Humanitas Clinical and Research Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
September 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibd (inflammatory bowel disease)